Skip to main content

Sarcevic Ademir's Form 4 filing

Standex International Corp (SXI) · filed Aug 25, 2026

Accession no.
0000310354-26-000072
Filed
Aug 25, 2026, 3:33 PM ET
Trade date
Aug 21-23, 2026
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 9 non-derivative transactions and 8 derivative transactions. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Sarcevic AdemirCIK 0001738830Officer (Vice President/CFO/Treasurer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 21, 2026Common StockMOption exerciseAcquired+602–F1–8,230Direct
Aug 21, 2026Common StockFTax withholdingDisposed−223$310.28−$69,192.448,007Direct
Aug 21, 2026Common StockMOption exerciseAcquired+1,693–F3–9,700Direct
Aug 21, 2026Common StockFTax withholdingDisposed−667$310.28−$206,956.769,033Direct
Aug 21, 2026Common StockFTax withholdingDisposed−327$310.28−$101,461.568,706Direct
Aug 21, 2026Common StockMOption exerciseAcquired+952–F4–9,658Direct
Aug 21, 2026Common StockFTax withholdingDisposed−375$310.28−$116,3559,283Direct
Aug 21, 2026Common StockMOption exerciseAcquired+830–F4–10,113Direct
Aug 21, 2026Common StockFTax withholdingDisposed−327$310.28−$101,461.569,786Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 21, 2026Common StockMOption exerciseDisposed−602–F1–0Direct
Aug 21, 2026Common StockMOption exerciseDisposed−1,693–F3–798Direct
Aug 21, 2026Common StockDReturned to the companyDisposed−798–F5–0Direct
Aug 21, 2026Common StockMOption exerciseDisposed−952–F4–952Direct
Aug 21, 2026Common StockMOption exerciseDisposed−830–F4–1,660Direct
Aug 23, 2026Common StockAGrant or awardAcquired+1,933–F6–1,933Direct
Aug 23, 2026Common StockAGrant or awardAcquired+1,933–F7–1,933Direct
Aug 23, 2026Common StockAGrant or awardAcquired+10,571–F8–10,571Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Vesting of Phantom Stock pursuant to Company's Management Stock Purchase Plan.

Referenced by the price of 1 transaction in Table I and 1 transaction in Table II.

F3

Vesting of Phantom Stock pursuant to the Company's 2018 Omnibus Incentive Plan. Actual achievement, which could have ranged from 0% to 250% of the award, was 68%. The transaction reported herein is the actual number of shares vesting pursuant thereto.

Referenced by the price of 1 transaction in Table I and 1 transaction in Table II.

F4

Vesting of Restricted Stock Units pursuant to the Company's 2018 Omnibus Incentive Plan.

Referenced by the price of 2 transactions in Table I and 2 transactions in Table II.

F5

Vesting of Phantom Stock pursuant to the Company's 2018 Omnibus Incentive Plan. Actual achievement, which could have ranged from 0% to 250% of the award, was 68%. Phantom Stock Units were granted at 100% achievement, so this transaction reflects the disposition of shares to accurately reflect the vesting.

Referenced by the price of 1 transaction in Table II.

F6

Award of Performance Share Units pursuant to the 2018 Omnibus Incentive Plan of the Company. These shares cliff vest at the end of a three year performance period with the ultimate number of shares ranging from 0 to 250% of the award based on achievement against Company performance metrics of the three year period.

Referenced by the price of 1 transaction in Table II.

F7

Grant of Restricted Stock Units pursuant to the 2018 Omnibus Incentive Plan of the Company which vests one-third per year on each anniversary of the date of the award.

Referenced by the price of 1 transaction in Table II.

F8

Premium Priced Stock Option with exercise price 10% above the closing market price on the date of grant. Option vests 25% per year on each anniversary of the date of the award for four years.

Referenced by the price of 1 transaction in Table II.

Read the full filing on SEC EDGAR (opens in a new tab)